Helen of Troy Q4
This article was originally published in The Rose Sheet
Executive Summary
North American sales from continuing operations, excluding the recently-divested Tactica depilatory business, grew 20.8% in the quarter (ended Feb. 29) to $98.7 mil., driven by strong performances from Vidal Sassoon,Dr. Scholl's,Revlon, Hot Tools and Wigo, firm reports May 13. Net sales from continuing operations grew 25.9% to $112.9 mil. in the quarter, while net earnings increased 92.1% to $16.3 mil. Full year net sales grew 25% to $474.9 mil., and net earnings jumped 89.4% to $71.6 mil. Net earnings including Tactica were up 16.4% to $7.5 mil. in Q4 and increased 56.3% to $60.5 mil. in fiscal 2004. Firm is raising its earnings per diluted share guidance for fiscal 2005 to $2.50-$2.70 from $2.30-$2.40 and expects Q1 2005 sales to increase 8%-16% to $98 mil.-$106 mil...